| Literature DB >> 27009064 |
Tuan Azlin Tuan Abdul Aziz1,2, Lay Kek Teh3,4, Muhd Hanis Md Idris1,2, Zakaria Bannur1,2, Lydiatul Shima Ashari5, Adzrool Idzwan Ismail6, Aminuddin Ahmad7, Kamarudzaman Md Isa6, Fadzilah Mohd Nor7, Thuhairah Hasrah Abdul Rahman7, Syahrul Azlin Binti Shaari7, Hamid Jan Jan Mohamed5, Nornazliya Mohamad1, Mohd Zaki Salleh8,9.
Abstract
BACKGROUND: Despite the strategic development plan by the authorities for the Orang Asli, there are six subtribes of which their population numbers are small (less than 700). These minorities were not included in most of the health related studies published thus far. A comprehensive physiological and biomedical updates on these small subtribes in comparison to the larger subtribes and the urban Malay population is timely and important to help provide appropriate measures to prevent further reduction in the numbers of the Orang Asli.Entities:
Keywords: Biochemical profiles; Framingham Risk Score; Health status; Insulin resistance; Lipid profiles; Liver functions; Orang Asli
Mesh:
Substances:
Year: 2016 PMID: 27009064 PMCID: PMC4806488 DOI: 10.1186/s12889-016-2848-9
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Study design
Fig. 2Location and population size of Orang Asli participated in the study
General characteristic of the Orang Asli and Malays that particiated in this study
| Characteristics | Orang Asli | Malays | Total, n (%) | |
|---|---|---|---|---|
| Inland, n (%) | Periphery, n (%) | Urban, n (%) | ||
| Overall | 96 (31.4) | 95 (31.0) | 115 (37.6) | 306 (100) |
| Age groups (years) | ||||
| 15–18 | 5 (1.70) | 8 (2.7) | 12 (4.0) | 25 (8.4) |
| 19–29 | 38 (12.8) | 42 (14.1) | 66 (22.2) | 146 (49.2) |
| 30–49 | 36 (12.1) | 28 (9.4) | 33 (11.1) | 97 (32.7) |
| 50–59 | 9 (3.0) | 11 (3.7) | 1 (0.3) | 21 (7.1) |
| >60 | 5 (1.7) | 3 (1.0) | 0 | 8 (2.7) |
| Gender | ||||
| Male | 57 (51.4) | 28 (25.2) | 26 (23.4) | 111 (36.3) |
| Female | 39 (20.0) | 67 (34.4) | 89 (45.6) | 195 (63.7) |
| Tribes | ||||
| Semai | 43 (14.1) | 0 | - | 43 (14.1) |
| Bateq | 27 (8.8) | 0 | - | 26 (8.8) |
| Che Wong | 0 | 28 (9.2) | - | 28 (9.2) |
| Kanaq | 0 | 11 (3.6) | - | 11 (3.6) |
| Kensiu | 0 | 56 (18.3) | - | 56 (18.3) |
| Lanoh | 26 (8.5) | 0 | - | 26 (8.5) |
Comparison of biochemical profiles among the male Orang Asli and male Urban Malays
| Biochemical profiles | Asian Reference range | Orang Asli (male) | CV | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Inland | Periphery | ||||||||
| Semai ( | Bateq ( | Lanoh ( | Kanaq ( | Kensiu ( | Che Wong ( | Malay ( | |||
| Lipid profile | |||||||||
| TC, mmol/La | Mean (SD) | 3.95 (0.96) | 4.09 (0.73) | 5.13 (1.12)c,d | 3.45 (0.21) | 4.59 (0.90) | 5.01 (1.22) | 5.59 (0.88)c,d,g,h | 0.81 |
| % of the subjects | >5.2 | 5.26 | 4.35 | 46.67 | 0 | 35.29 | 55.56 | 69.23 | |
| HDL-C, mmol/La | Mean (SD) | 0.99 (0.18) | 1.14 (0.23) | 1.18 (0.37) | 0.70 (0.00)c,d,h,i | 1.18 (0.45) | 1.00 (0.51) | 1.48 (0.29)c,d,g | 1.13 |
| % of the subjects | <1.0 | 31.50 | 21.74 | 40.00 | 100 | 29.41 | 55.56 | 0 | |
| LDL-C, mmol/La | Mean (SD) | 2.34 (0.85) | 2.52 (0.63) | 3.25 (0.90)c | 2.15 (0.35) | 2.88 (0.95) | 3.29 (1.19) | 3.67 (0.81)c,d | 1.10 |
| % of the subjects | >4.1 (very high risk) | 0 | 0 | 20.00 | 0 | 11.76 | 22.22 | 34.62 | |
| <4.1 (high risk) | 15.79 | 8.70 | 13.33 | 0 | 23.53 | 33.33 | 23.08 | ||
| <3.4 (moderate) | 21.05 | 39.13 | 46.67 | 0 | 29.41 | 33.33 | 34.62 | ||
| <2.6 (low risk) | 63.16 | 52.17 | 20.00 | 100 | 35.29 | 11.11 | 7.69 | ||
| TG, mmol/La | Mean (SD) | 1.36 (0.96) | 0.91 (0.36) | 1.61 (0.82)d | 1.15 (0.21) | 1.17 (0.50) | 1.59 (0.82) | 1.00 (0.34) | 1.60 |
| % of the subjects | >1.7 | 26.32 | 8.70 | 33.33 | 0 | 11.76 | 33.33 | 7.69 | |
| Endocrine tests | |||||||||
| FBG, mmol/Lb | Mean (SD) | 5.05 (1.00) | 5.10 (0.80) | 5.70 (3.00)c,d | 5.85 (0.00) | 5.80 (2.40)c | 5.30 (0.80) | 4.90 (0.50)h,i | 0.38 |
| % of the subjects | 3.5–6.0 (normal) | 88.89 | 86.36 | 50.00 | 100 | 53.33 | 88.89 | 96.00 | |
| 6.1–6.9 (IFG) | 11.11 | 9.09 | 21.43 | 0 | 20.00 | 11.11 | 4.00 | ||
| >7.0 (DM) | 0 | 4.55 | 28.57 | 0 | 26.67 | 0 | 0 | ||
| HbAlc, %b | Mean (SD) | 5.20 (0.50) | 5.30 (0.40) | 5.45 (0.60) | - | 5.2 | 5.20 (0.60) | 5.40 (0.40) | 0.80 |
| % of the subjects | <4.8 | 5.26 | 0 | 7.14 | - | 0 | 11.11 | 11.54 | |
| 4.8–5.9 | 94.74 | 100.00 | 78.57 | - | 100.00 | 88.89 | 88.46 | ||
| >5.9 | 0 | 0 | 14.29 | - | 0 | 0 | 0 | ||
| Insulin, pmol/La | Mean (SD) | 91.57 (86.82) | 95.89 (88.44) | 176.95 (220.37) | 17.7 (4.67)e,i | 98.06 (102.28) | 140.88 (111.56) | 66.54 (83.29) | 1.70 |
| % of the subjects | <17.8 | 15.79 | 0 | 0 | 50.00 | 5.88 | 0 | 3.85 | |
| 17.8–173.0 | 68.42 | 73.91 | 80.00 | 50.00 | 82.35 | 55.56 | 92.31 | ||
| >173.0 | 15.79 | 26.09 | 20.00 | 0 | 11.76 | 44.44 | 3.85 | ||
| hs-CRP, nmol/La | Mean (SD) | 10.55 (10.72) | 21.28 (23.87) | 28.02 (36.90) | 28.10 (24.89) | 8.81 (17.51)d,i | 10.24 (15.42) | 16.38 (21.26) | 0.60 |
| % of the subjects | <9.5 (low risk) | 68.42 | 39.13 | 46.67 | 0 | 82.35 | 66.67 | 61.54 | |
| 9.5–28.6 (moderate) | 21.05 | 39.13 | 26.67 | 50.00 | 5.88 | 22.22 | 15.38 | ||
| >28.6 (high risk) | 10.53 | 21.74 | 26.67 | 50.00 | 11.76 | 11.11 | 23.08 | ||
| Renal profile | |||||||||
| Urea, mmol/La | <8.3 | 4.00 (1.51) | 4.07 (1.18) | 3.35 (0.89) | 6.55 (3.75) | 2.92 (1.32) | 3.24 (106) | 4.28 (0.58)h | 2.30 |
| Creatinine, mol/La | <106 | 83.68 (10.57) | 82.00 (7.56) | 79.07 (18.12) | 148.50 (86.97) | 74.65 (16.54) | 61.11 (11.58)c,d | 90.56 (12.48)e | 3.10 |
| Sodium, mmol/La | 136.0–145.0 | 140.33 (1.41) | 137.74 (1.57)c | 136.47 (2.70)c,e | 139.00 (0.00) | 138.38 (2.79) | 139.50 (195) | 137.78 (1.56)c | 0.24 |
| Potassium, nmol/La | 3.5–5.1 | 4.26 (0.38) | 3.91 (0.28)c | 3.75 (0.30)c | 4.30 (0.14) | 4.72 (0.48)c | 4.33 (0.42)h,i | 4.77 (0.62)d,h,i | 0.44 |
| Liver function tests | |||||||||
| Albumin, g/Lb | 35.0–52.0 | 45.60 (4.40) | 47.40 (3.00)c | 48.50 (5.70)c | 43.80 (0.00) | 45.90 (4.00)i | 46.60 (5.70) | 50.40 (3.10)c,d,g,h | 1.90 |
| Total protein, g/La | 66.0–87.0 | 73.98 (3.28) | 77.30 (4.13) | 79.21 (7.09) | 71.90 (2.55) | 75.40 (7.32) | 78.80 (6.41) | 76.41 (4.10) | 1.12 |
| ALP, U/Lb | 40.0–129.0 | 82.10 (20.40) | 91.50 (39.00) | 79.70 (47.60) | 80.35 (0.00) | 102.30 (38.40) | 67.00 (14.60)c,d,h | 66.20 (17.40)c,d,h,i | 1.60 |
| ALT, U/La | <41.0 | 17.70 (5.94) | 15.49 (6.81) | 9.50 (4.90)c,d | 12.10 (0.42)c | 18.90 (10.44)i | 27.18 (28.00) | 22.47 (12.89)g,i | 1.00 |
| Direct bilirubin, pmol/La | <5.1 | 2.32 (1.27) | 3.03 (1.19) | 4.03 (1.35)c | 1.94 (0.93)d,i | 0.96 (0.24)c,d,h,i | 3.62 (1.23)c,e,h | 6.40 | |
| Total bilirubin, pmol/La | <21.0 | 9.23 (4.16) | 8.28 (3.29) | 11.25 (4.75) | 4.51 (2.73)c,d,i | 3.03 (1.43)c,d,i | 10.60 (4.50)e,h | 0.46 | |
| Ferritin, pmol/La | 67.4–898.8 | 304.16 (212.38) | 138.67 (153.18)c | 341.41 (343.90) | 143.55 (82.94) | 113.82 (110.64)c | 91.50 (57.19) | 340.56 (218.71)d,e,h | 1.80 |
| GGT, U/Lb | <60.0 | 17.50 (11.80) | 23.80 (34.00) | 23.40 (31.80) | 14.15 (0.00) | 25.50 (63.30) | 17.40 (36.40) | 23.95 (17.30) | 1.80 |
SD standard deviation, TC total cholesterol, HDL-c high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, TG triglyceride, FBG fasting plasma glucose, HbA1c glycated haemoglobin; hs-CRP, high-sensitive C-reactive protein; ALP, alkaline phosphatase, ALT alanine transaminase, GGT gamma-glutamyltransferase
aExpressed as mean and standard deviation
bExpressed as median and interquartile range due to skewed distribution, and the p-value was based on variance analysis Kruskal Wallis or Mann Whitney test
cp < 0.05 as compared to Semai
dp < 0.05 as compared to Bateq
ep < 0.05 as compared to Che Wong
fp < 0.05 as compared to Malays
gp < 0.05 as compared to Kanaq
hp < 0.05 as compared to Kensiu
ip < 0.05 as compared to Lanoh
Comparison of biochemical profiles among the female Orang Asli and female Urban Malays
| Biochemical profiles | Asian Reference range | Orang Asli (female) | CV | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Inland | Periphery | ||||||||
| Semai | Bateq | Lanoh | Kanaq | Kensiu | Che Wong ( | Malay | |||
| Lipid profile | |||||||||
| TC, mmol/La | Mean (SD) | 4.35 | 4.35 (0.71) | 4.90 (1.22) | 4.91 | 4.60 (0.98) | 5.28 (1.37)c | 5.20 (0.85)c,h | 0.81 |
| % of the subjects | >5.2 | 25.00 | 0 | 45.45 | 33.33 | 25.64 | 47.37 | 49.44 | |
| HDL-C, mmol/Lb | Mean (SD) | 1.10 | 1.45 | 1.20 (0.60) | 0.90 | 0.90 | 1.20 | 1.70 (0.50)c,e,g,h,i | 1.13 |
| % of the subjects | <1.0 | 16.67 | 0 | 36.36 | 66.67 | 51.28 | 31.58 | 1.12 | |
| LDL-C, mmol/La | Mean (SD) | 2.77 | 2.58 (0.53) | 3.16 (1.01) | 3.38 | 3.09 (0.93) | 3.55 (1.05) | 3.15 (0.78) | 1.10 |
| % of the subjects | >4.1 (very high risk) | 4.17 | 0 | 18.18 | 33.33 | 10.26 | 21.05 | 14.77 | |
| <4.1 (high risk) | 16.67 | 0 | 27.27 | 11.11 | 33.33 | 31.58 | 20.45 | ||
| <3.4 | 45.83 | 50.00 | 36.36 | 55.56 | 17.95 | 31.58 | 43.18 | ||
| <2.6 (low risk) | 33.33 | 50.00 | 18.18 | 0 | 38.46 | 15.79 | 21.59 | ||
| TG, mmol/Lb | Mean (SD) | 0.85 | 0.60 (0.50) | 1.00 (0.80) | 1.40 | 0.90 | 0.80 (0.50)g | 0.70 (0.40)g,h | 1.60 |
| % of the subjects | >1.7 | 16.67 | 0 | 18.18 | 11.11 | 10.26 | 15.79 | 3.37 | |
| Endocrine tests | |||||||||
| FBG, mmol/Lb | Mean (SD) | 4.80 | 5.95 (0.40) | 5.40 | 4.90 | 4.90 | 4.90 | 4.90 (0.50)c,h,i | 0.38 |
| % of the subjects | 3.5–6.0 | 91.67 | 50.00 | 72.72 | 62.50 | 83.33 | 94.74 | 100.00 | |
| 6.1–6.9 | 8.33 | 50.00 | 27.27 | 25.00 | 5.56 | 5.26 | 0 | ||
| >7.0 (DM) | 0 | 0 | 0 | 12.50 | 11.11 | 0 | 0 | ||
| HbAlc, %a | Mean (SD) | 5.05 | 5.03 (0.47) | 5.33 (0.29) | - | 5.43 | 5.16 (0.21)h | 5.35 (0.24)c | 0.80 |
| % of the subjects | <4.8 | 17.39 | 33.33 | 0 | - | 0 | 0 | 0 | |
| 4.8–5.9 | 82.61 | 66.67 | 90.91 | - | 94.44 | 100.00 | 98.86 | ||
| >5.9 | 0 | 0 | 9.09 | - | 5.55 | 0 | 1.14 | ||
| Insulin, pmol/Lb | Mean (SD) | 52.40 | 62.30 | 133.80 | 19.90 | 47.2 | 169.30 | 47.10 (34.50)e,g,i | 1.70 |
| % of the subjects | <17.8 | 0 | 25.00 | 0 | 22.22 | 20.51 | 0 | 3.37 | |
| 17.8–173.0 | 91.67 | 75.00 | 63.64 | 66.67 | 10.53 | 52.63 | 94.38 | ||
| >173.0 | 8.33 | 0 | 36.36 | 0 | 72.22 | 47.37 | 0 | ||
| hs-CRP, nmol/Lb | Mean (SD) | 8.70 | 27.60 | 32.40 | 16.2 | 5.00 | 9.40 (37.20) | 5.70 (10.00)c,i | 0.60 |
| % of the subjects | <9.5 (low risk) | 54.17 | 50.00 | 36.36 | 33.33 | 17.95 | 52.63 | 15.73 | |
| 9.5–28.6 | 33.33 | 0 | 9.09 | 22.22 | 64.10 | 15.79 | 70.79 | ||
| >28.6 (high risk) | 12.50 | 50.00 | 54.55 | 44.44 | 17.95 | 31.58 | 13.48 | ||
| Renal profile | |||||||||
| Urea, mmol/La | <8.3 | 3.25 | 3.93 (0.74) | 3.47 (1.72) | 3.09 | 2.82 (0.96) | 3.32 (0.67) | 3.25 (0.80) | 2.30 |
| Creatinine, | <80 | 58.92 | 66.00 | 62.91 | 83.78(12.4 | 58.87(11.4 | 71.68(14.94 | 57.42(7.20)e,g | 3.10 |
| micromol/La | (8.97) | (19.51) | (21.48) | 3)c | 1)g | ) | |||
| Sodium, mmol/Lb | 136.0–145.0 | 139.95 | 140.00(8.80) | 138.00 | 138.00 | 142.00 | 140.70 | 137.00 | 0.24 |
| Potassium nmol/La | 3.5–5.1 | 4.00 | 3.53 (0.57) | 3.53 | 4.10 | 3.78 | 4.13 | 4.69 (0.45)c,e,g,h,i | 0.44 |
| Liver function tests | |||||||||
| Albumin, g/Lb | 35.0–52.0 | 44.45 | 45.90 | 46.20 | 46.20 | 44.50 | 48.90 | 49.20 (3.70)g,h,i | 1.90 |
| Total protein, g/Lb | 66.0–87.0 | 73.45 | 77.45 | 81.70 | 77.80 | 75.20 | 79.10 | 77.40 (6.70)c,h,i | 1.12 |
| ALP, U/La | 35.0–104.0 | 79.76 | 92.55 | 89.80 | 76.86 | 80.06 | 73.73 | 60.18 | 1.60 |
| ALT, U/La | <33.0 | 16.60 | 14.98 | 13.59 | 9.17 | 14.25 | 27.31 | 11.80 (7.74)c,e | 1.00 |
| Direct bilirubin, pmol/Lb | <5.1 | 2.00 | 2.20 (2.20) | 2.80 | - | 0.80 | 0.90 | 2.40 (1.20)c,e,h | 6.40 |
| Total bilirubin, pmol/La | <21.0 | 8.49 | 6.90 (2.95) | 9.51 (5.52) | - | 3.39 | 4.43 | 7.04 (2.91)c,h,i | 0.46 |
| GGT, U/Lb | <40.0 | 14.45 | 23.70 | 15.80 | 8.20 | 20.90 | 17.40 | 10.30 (6.10)c,d,e,h | 1.80 |
| Ferritin, pmol/Lb | 29.2–337.1 | 167.20 | 35.05 | 86.70 | 50.80 (145.10)c,i | 54.40 | 40.90 | 96.00 | 1.80 |
SD standard deviation, TC total cholesterol, HDL-c high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, TG triglyceride, FBG fasting plasma glucose, HbAlc glycated haemoglobin, hs-CRP high-sensitive C-reactive protein, ALP alkaline phosphatase, ALT alanine transaminase, GGT gamma-glutamyltransferase
aExpressed as mean and standard deviation
bExpressed as median and interquartile range due to skewed distribution, and the p-value was based on variance analysis Kruskal Wallis or Mann Whitney test
cp < 0.05 as compared to Semai
dp < 0.05 as compared to Bateq
ep < 0.05 as compared to Che Wong
fp < 0.05 as compared to Malays
gp < 0.05 as compared to Kanaq
hp < 0.05 as compared to Kensiu
ip < 0.05 as compared to Lanoh
Framingham Risk Score of the Orang Asli and healthy unrelated Malays
| Framingham Risk Score, FRS (%) | ||||||
|---|---|---|---|---|---|---|
| Male | Female | |||||
| Inland ( | Periphery ( | Urban ( | Inland ( | Periphery ( | Urban ( | |
| Low risk | 58.0 | 66.6 | 100 | 79.2 | 75.0 | 100 |
| Moderate risk | 21.0 | 16.7 | - | 16.6 | 25.0 | - |
| High risk | 21.0 | 16.7 | - | 4.2 | - | - |